facebook
twitter
rss
account
search
search
 

Test improves prostate cancer diagnosis

April 26, 2007 at 9:53 PM   |   Comments

WASHINGTON, April 26 (UPI) -- U.S. researchers say an experimental blood test for prostate cancer may detect more tumors and reduce unnecessary biopsies.

In a study published in the April issue of the journal Urology, Johns Hopkins Hospital researchers said EPCA-2 testing is more accurate than the current PSA test in identifying cancer in the prostate.

The PSA test measures a protein normally produced by the prostate, while EPCA-2 detects a chemical primarily made in cancerous tissue, The Washington Post reported.

Robert H. Getzenberg -- professor of urology and director of research at the James Buchanan Brady Urological Institute at The Johns Hopkins University School of Medicine -- said PSA testing often erroneously highlights non-cancerous conditions and can miss some cases of cancer.

Getzenberg, lead author of the study, said approximately 1.6 million men undergo prostatic biopsies in the United States annually, and roughly 80 percent of them have negative results.

Johns Hopkins Hospital is working with Onconome Inc., a biomedical company based in Seattle, to bring the test to market within the next 18 months.

© 2007 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
Most Popular
1
Ancient Europeans couldn't drink milk for 5,000 years Ancient Europeans couldn't drink milk for 5,000 years
2
Global warming is shrinking alpine goats Global warming is shrinking alpine goats
3
Solar eclipse will partially obscure the sun Thursday Solar eclipse will partially obscure the sun Thursday
4
Mental rest and reflection key to better learning Mental rest and reflection key to better learning
5
DC drone hobbyists in limbo over flying locations DC drone hobbyists in limbo over flying locations
Trending News
Around the Web
x
Feedback